drugset / Trial / NCT00865137

An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

NCT00865137

Phase 3 Completed 27 enrolled Astellas Pharma Inc
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of food on the oral bioavailability of tacrolimus modified release (MR4) capsules together with a standard continental breakfast. The objective is to assess the pharmacokinetics and relative bioavailability with and without food.

Timeline

Start
2007-09
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule Oral

Indications

No indication recorded.